Immune cells are thought to be inactivated in tumor microenvironment, via the engagement of inhibitory receptors such as the famous Cytotoxic T-Lymphocyte Associated Protein 4(CTLA4) and Programmed cell death protein 1 (PD-1) [4–6]. The gene discussed is CTLA4; the disease is neoplasm.